Drug profile · INN
fidaxomicin
DIFICLIR
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
fidaxomicin (DIFICLIR) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN fidaxomicin
Brand DIFICLIR
Route ORAL
Formulation TABLET
ATC code A07AA12
Frequently asked questions
What is fidaxomicin?
fidaxomicin (DIFICLIR) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for fidaxomicin?
DIFICLIR is a marketed brand name for fidaxomicin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of fidaxomicin?
fidaxomicin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.